Adolescent obesity and the elevation of aminotransferase levels

청소년 비만과 혈청 아미노 전이 효소 증가

  • Kim, Su Yeon (Department of Pediatrics, National Medical Center) ;
  • Lee, Ho Jun (Department of Pediatrics, National Medical Center) ;
  • Park, Tae Su (Department of Pediatrics, National Medical Center) ;
  • Kim, Soo Geun (Radiation Health Research Institute) ;
  • Shin, Hye Jung (Department of Pediatrics, National Medical Center)
  • Received : 2006.06.26
  • Accepted : 2006.08.28
  • Published : 2006.10.15

Abstract

Purpose : The prevalence of obesity and nonalcoholic steatohepatitis(NASH) was increased in adolescents. This study was performed to observe the prevalence of elevated aminotransferase levels in adolescents and to assess the correlations between aminotransferase levels and obesity related parameters(body mass index, waist circumference, hip circumference, waist to hip ratio and insulin level). Methods : We obtained weight, height, waist circumference and hip circumference from 2,417 male and 1,219 female adolescents. Mean age was $15.7{\pm}0.7$ years old. We measured fasting insulin, aspartate aminotransferase(AST) and alanine aminotransferase(ALT). Obese and overweight were defined as body mass indices(BMI) of more than the 95th, and 85th-94th percentiles, respectively, for age and sex. Results : The number of adolescents with obesity is 324(8.9 percent). 414(11.4 percent) subjects belonged to the overweight group. The average ALT level of obese, overweight and control groups were significantly different(obese : $32.1{\pm}34.3U/L$, overweight : $19.6{\pm}13.6U/L$, control : $12.7{\pm}6.7U/L$, P<0.001). The average AST level was also different according to group(obese : $27.8{\pm}16.5U/L$, overweight : $22.8{\pm}8.6U/L$, control : $20.8{\pm}8.5U/L$, P<0.001). AST and ALT were correlated with anthropometric parameters and insulin level. After multiple regression analysis, waist circumference was the significant predictive value for AST(r=0.234, P<0.001). Waist circumference, BMI and insulin levels were significant predictive values for ALT(r=0.435, P<0.001). Conclusion : The prevalence of abnormal aminotransferase was higher in the obese and overweight groups than control group. Waist circumference was useful to predict abnormal aminotransferase levels.

목 적 : 소아에서 비만 유병률 증가와 함께 비알콜성 지방간염도 증가하고 있다. 본 연구에서는 청소년에서 혈청 아미노 전이 효소 상승 빈도를 조사하고 체지방 분포 및 혈청 인슐린 농도와의 관계를 알아보고자 한다. 방 법 : 3,636명을 대상으로 하였고 이들의 평균 연령은 $15.7{\pm}0.7$세였다. 대상자로부터 신장, 체중, 허리둘레, 둔위를 측정하고 혈액검사를 통하여 AST, ALT및 공복시 인슐린을 측정하였다. 비만 및 과체중군은 성별, 연령별 체질량지수와 비교하여 각각 95 백분위수 이상, 85-94 백분위수로 정의하였다. 결 과 : 비만군은 324명으로 8.9%였으며 과체중군은 414명(11.4%)이었다. 허리둘레와 둔위 및 허리-둔위비는 남녀학생 모두에서 각 군간에 유의한 차이를 보였다. ALT 평균치는 각 군간에 유의한 차이를 보였다(비만군 : $32.1{\pm}34.3U/L$, 과체중 : $19.6{\pm}13.6U/L$, 대조군 : $12.7{\pm}6.7U/L$, P<0.001). AST 평균치 또한 각 군별로 유의한 차이를 보였다(비만군 : $27.8{\pm}16.5U/L$, 과체중군 : $22.8{\pm}8.6U/L$, 대조군 : $20.8{\pm}8.5U/L$, P<0.001). AST 및 ALT는 체질량지수, 허리둘레, 둔위, 허리-둔위비 및 혈청 인슐린 농도와 각각 유의한 상관 관계를 가졌다. 다중회귀분석결과 여러 신체 계측치와 인슐린 농도 중에서 ALT와 유의한 상관 관계를 갖는 것은 허리둘레, 체질량지수, 인슐린 농도 였으며(r=0.435, P<0.001), AST에 영향을 주는 인자는 허리둘레였다(r=0.234, P<0.001). 결 론 : 비만군 및 과체중군에서 혈청 아미노 전이 효소 증가대상자의 비율이 의미 있게 증가되어 있었고 허리둘레는 AST 및 ALT 증가를 예측하는데 유용한 지표로 사용될 수 있다.

Keywords

References

  1. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hypertransaminasemia resolving after weight reduction in obese children. J Pediatr 1994; 125:239-41 https://doi.org/10.1016/S0022-3476(94)70202-0
  2. Tazawa Y, Noguchi H, Nishiomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr 1997;86:238-41 https://doi.org/10.1111/j.1651-2227.1997.tb08881.x
  3. Kral JG, Schaffner F, Pierson RN Jr, Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism 1993;42:549-51
  4. Marchesini G, Brizi M, Morselli-labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-5 https://doi.org/10.1016/S0002-9343(99)00271-5
  5. Kerkar N. Non-alcoholic steatohepatitis in children. Pediatr Transplant 2004;8:613-8 https://doi.org/10.1111/j.1399-3046.2004.00241.x
  6. Park YS, Lee DH, Choi JM, Kang YJ, Kim CH. Trend of obesity in school age children in Seoul over the past 23 years. Korean J Pediatr 2004;47:247-57
  7. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis; Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8
  8. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45 https://doi.org/10.7326/0003-4819-126-2-199701150-00008
  9. Nasrallah SM, Wills CE Jr, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci 1981;26:325-7 https://doi.org/10.1007/BF01308373
  10. Anderson T, Glud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984;8:97-106
  11. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-23 https://doi.org/10.1016/S0016-5085(00)70364-7
  12. Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000;75:733-9 https://doi.org/10.4065/75.7.733
  13. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62 https://doi.org/10.1002/hep.510300604
  14. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children : a cause of chronic liver dysfunction. Am J Gastroenterol 1983;78:374-7
  15. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000;30:48-53 https://doi.org/10.1097/00005176-200001000-00017
  16. Molleston JP, White F, Teckmann J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002;97:2460-2 https://doi.org/10.1111/j.1572-0241.2002.06003.x
  17. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984;3:408-14 https://doi.org/10.1097/00005176-198406000-00018
  18. Wanless IR, Lentz JS. Fatty liver hepatitis(steatohepatitis) and obesity : an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10 https://doi.org/10.1002/hep.1840120505
  19. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Teri BA. Nonalcoholic steatohepatitis : an expanded clinical entity. Gastroenterology 1994;107:1103-9 https://doi.org/10.1016/0016-5085(94)90235-6
  20. Contos MJ, Sanyal AJ. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 2002;9:37-51 https://doi.org/10.1097/00125480-200201000-00005
  21. Jonas MM. Nonalcoholic fatty liver disease. Adolesc Med Clin 2004;15:159-73 https://doi.org/10.1016/j.admecli.2003.11.010
  22. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-9 https://doi.org/10.1007/BF02208670
  23. Han BH, Kim DH, Park YK, Lee JH, Kim HS. Incidence and complication of obesity in pubescent school children. J Korean Pediatr Soc 1995;38:520-8
  24. Park JH, Son CS, Lee JW, Dokgo YC. Obesity in elementary school children. J Korean Pediatr Soc 1993;36:338-45
  25. Choi YH, Jeon YH, Kim SK, Han SK, Son BK, Choi JW, et al. Complications, apolipoproteins and lipoprotein(a) in severely obese children in Incheon, 1996. J Korean Pediatr Soc 1997;40:1386-93
  26. Lee DH, Lee JK, Lee C, Hwang YS, Cha SH, Choi Y. The incidence of complications in severely obese children. J Korean Pediatr Soc 1991;34:445-53
  27. Seo JH. The prevalence of childhood and adolescent obesity in Jeju and clinical characteristics according to the degree of obesity. Korean J Pediatr 2004;47:362-7
  28. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 2001;358:893-4 https://doi.org/10.1016/S0140-6736(01)06042-1